Perspective Therapeutics Statistics
NYSE: CATXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.7538-0.0302 (-3.85%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Perspective Therapeutics by the numbers
Perspective Therapeutics has a market capitalization of $91.0 million based on 120.76M shares outstanding. With trailing EPS of $-1.25, Perspective Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 60.2% below its 50-day average and 77.5% below its 200-day average.
Average daily trading volume is 2.70M shares, or about $2.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CATX valuation vs. peer median
| Metric | CATX | Peer median | Difference |
|---|---|---|---|
| Market cap | $91.03M | $89.23M | +2% |
| Avg. volume | 2.70M | 188.81K | +1330% |
Peer median across 8 companies: NTHI, CLLS, DERM, CPIX, RTSN, EQ, UPB, NRXP.
Valuation
- Market cap
- $91.03M
- EPS (TTM)
- $-1.25
- Shares outstanding
- 120.76M
Price and trading
- Previous close
- 0.784
- Open
- 0.7589
- Day range
- 0.7407 – 0.79
- 52-week range
- 0.73 – 6.16
- 52-week change
- -63.93%
- Beta
- —
- Volume
- 1.39M
- Average volume
- 2.70M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 91.03M
- Forward Pe
- -0.72
- Eps
- -1.25
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 6.16
- Week52 Low
- 0.73
- Avg Volume
- 2.70M
- Shares Outstanding
- 120.76M
- Ma50
- 1.89
- Ma200
- 3.35
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -87.76%
- Pct From52w Low
- 3.26%